Founded in 1995, MONIPOL | Clinical Research is an owner-led CRO with German and Polish roots and strong regional partnerships across Europe. Leveraging over 25 years of experience in monitoring and organizing multicenter clinical trials, MONIPOL is committed to tailored solutions for the various needs of biotechnology and small and medium-sized pharma companies, to support them in bringing new and innovative therapies to market. MONIPOL’s offering includes the conduct of Phase I-IV clinical trials in a wide range of therapeutic areas, with a particular focus on vaccines / infections, oncology, and bioequivalence / biosimilars.
Role in TherVacB
MONIPOL is responsible for assuring the organization of the conduct of the clinical trial including regulatory submission and communication, project management, and monitoring.
Executive Director Clinical Development
Long-term experience in clinical research with a background in investigator-initiated trials (IITs), clinical operations, project management, and regulatory affairs for both national and European clinical trials.
Senior Project Manager & Regulatory Affairs Specialist
Expertise in regulatory submission of clinical trials as well as organizing and overseeing national and international clinical trials, especially vaccine trials.
Project Manager & Regulatory Affairs Specialist
Expertise in regulatory submission of clinical trials as well as organizing and overseeing national clinical trials.